阿尔茨海默病疫苗的挫折：经验教训 - Suppr

Suppr

超能文献

Setback for an Alzheimer's disease vaccine: lessons learned.

作者信息

Mathews Paul M, Nixon Ralph A

出版信息

Neurology. 2003 Jul 8;61(1):7-8. doi: 10.1212/wnl.61.1.7.

DOI:10.1212/wnl.61.1.7

PMID:12847147

Abstract

摘要

相似文献

Setback for an Alzheimer's disease vaccine: lessons learned.

Neurology. 2003 Jul 8;61(1):7-8. doi: 10.1212/wnl.61.1.7.

A new kind of Alzheimer's disease plaque.

Adv Anat Pathol. 1998 May;5(3):170-4. doi: 10.1097/00125480-199805000-00004.

Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.

J Alzheimers Dis. 2014;41(1):243-60. doi: 10.3233/JAD-132177.

Vaccine trial in Alzheimer's disease is halted.

Curr Neurol Neurosci Rep. 2003 Sep;3(5):371-2. doi: 10.1007/s11910-003-0018-9.

Amyloid-beta immunotherapy for Alzheimer's disease.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):197-206. doi: 10.2174/187152710791012017.

AD vaccines: conclusions and future directions.

CNS Neurol Disord Drug Targets. 2009 Apr;8(2):160-6. doi: 10.2174/187152709787847289.

Amyloid-beta vaccination for Alzheimer's dementia.

Lancet. 2008 Oct 18;372(9647):1381; author reply 1381-2. doi: 10.1016/S0140-6736(08)61579-2.

Value in development of a TAPIR-like mouse monoclonal antibody to Abeta.

J Alzheimers Dis. 2008 Jun;14(2):175-7. doi: 10.3233/jad-2008-14205.

Plaques and tangles: searching for primary events in a forest of data.

Neurobiol Aging. 1997 Jul-Aug;18(4):358-62; discussion 389-92. doi: 10.1016/s0197-4580(97)00049-3.

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.

Neurology. 2003 Jul 8;61(1):46-54. doi: 10.1212/01.wnl.0000073623.84147.a8.

引用本文的文献

Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease.

Hum Vaccin Immunother. 2014;10(7):2024-31. doi: 10.4161/hv.28735.

Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer's mice.

J Neuroimmune Pharmacol. 2012 Sep;7(3):640-55. doi: 10.1007/s11481-012-9371-2. Epub 2012 Jun 9.

The value of incomplete mouse models of Alzheimer's disease.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S70-4. doi: 10.1007/s00259-007-0704-y.

Immunological and anti-chaperone therapeutic approaches for Alzheimer disease.

Brain Pathol. 2005 Jan;15(1):72-7. doi: 10.1111/j.1750-3639.2005.tb00102.x.

Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.

Am J Pathol. 2004 Mar;164(3):757-61. doi: 10.1016/S0002-9440(10)63163-X.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Setback for an Alzheimer's disease vaccine: lessons learned.

Neurology. 2003 Jul 8;61(1):7-8. doi: 10.1212/wnl.61.1.7.

A new kind of Alzheimer's disease plaque.

Adv Anat Pathol. 1998 May;5(3):170-4. doi: 10.1097/00125480-199805000-00004.

J Alzheimers Dis. 2014;41(1):243-60. doi: 10.3233/JAD-132177.

Vaccine trial in Alzheimer's disease is halted.

Curr Neurol Neurosci Rep. 2003 Sep;3(5):371-2. doi: 10.1007/s11910-003-0018-9.

Amyloid-beta immunotherapy for Alzheimer's disease.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):197-206. doi: 10.2174/187152710791012017.

AD vaccines: conclusions and future directions.

CNS Neurol Disord Drug Targets. 2009 Apr;8(2):160-6. doi: 10.2174/187152709787847289.

Amyloid-beta vaccination for Alzheimer's dementia.

Lancet. 2008 Oct 18;372(9647):1381; author reply 1381-2. doi: 10.1016/S0140-6736(08)61579-2.

Value in development of a TAPIR-like mouse monoclonal antibody to Abeta.

J Alzheimers Dis. 2008 Jun;14(2):175-7. doi: 10.3233/jad-2008-14205.

Plaques and tangles: searching for primary events in a forest of data.

Neurobiol Aging. 1997 Jul-Aug;18(4):358-62; discussion 389-92. doi: 10.1016/s0197-4580(97)00049-3.

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.

Neurology. 2003 Jul 8;61(1):46-54. doi: 10.1212/01.wnl.0000073623.84147.a8.

引用本文的文献

Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease.

Hum Vaccin Immunother. 2014;10(7):2024-31. doi: 10.4161/hv.28735.

Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer's mice.

J Neuroimmune Pharmacol. 2012 Sep;7(3):640-55. doi: 10.1007/s11481-012-9371-2. Epub 2012 Jun 9.

The value of incomplete mouse models of Alzheimer's disease.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S70-4. doi: 10.1007/s00259-007-0704-y.

Immunological and anti-chaperone therapeutic approaches for Alzheimer disease.

Brain Pathol. 2005 Jan;15(1):72-7. doi: 10.1111/j.1750-3639.2005.tb00102.x.

Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.

Am J Pathol. 2004 Mar;164(3):757-61. doi: 10.1016/S0002-9440(10)63163-X.